- Home
- GPRK vs HUMA Comparison
GPRK vs HUMA Comparison
Compare GPRK & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- HUMA
- Stock Information
- Founded
- GPRK 2002
- HUMA 2004
- Country
- GPRK Colombia
- HUMA United States
- Employees
- GPRK N/A
- HUMA N/A
- Industry
- GPRK Oil & Gas Production
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- GPRK Energy
- HUMA Health Care
- Exchange
- GPRK Nasdaq
- HUMA Nasdaq
- Market Cap
- GPRK 335.7M
- HUMA 250.2M
- IPO Year
- GPRK N/A
- HUMA N/A
- Fundamental
- Price
- GPRK $6.60
- HUMA $1.51
- Analyst Decision
- GPRK Buy
- HUMA Strong Buy
- Analyst Count
- GPRK 1
- HUMA 8
- Target Price
- GPRK $11.00
- HUMA $10.88
- AVG Volume (30 Days)
- GPRK 689.9K
- HUMA 5.9M
- Earning Date
- GPRK 08-05-2025
- HUMA 08-11-2025
- Dividend Yield
- GPRK 8.91%
- HUMA N/A
- EPS Growth
- GPRK N/A
- HUMA N/A
- EPS
- GPRK 0.81
- HUMA N/A
- Revenue
- GPRK $560,354,000.00
- HUMA $818,000.00
- Revenue This Year
- GPRK N/A
- HUMA N/A
- Revenue Next Year
- GPRK N/A
- HUMA $949.92
- P/E Ratio
- GPRK $8.19
- HUMA N/A
- Revenue Growth
- GPRK N/A
- HUMA N/A
- 52 Week Low
- GPRK $5.66
- HUMA $1.15
- 52 Week High
- GPRK $11.72
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- GPRK 50.84
- HUMA 36.87
- Support Level
- GPRK $6.28
- HUMA $1.43
- Resistance Level
- GPRK $6.67
- HUMA $1.67
- Average True Range (ATR)
- GPRK 0.20
- HUMA 0.15
- MACD
- GPRK 0.02
- HUMA -0.01
- Stochastic Oscillator
- GPRK 63.01
- HUMA 23.32
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.